Naama Levy‐Cooperman

920 total citations
35 papers, 716 citations indexed

About

Naama Levy‐Cooperman is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Pharmacology. According to data from OpenAlex, Naama Levy‐Cooperman has authored 35 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 14 papers in Anesthesiology and Pain Medicine and 8 papers in Pharmacology. Recurrent topics in Naama Levy‐Cooperman's work include Opioid Use Disorder Treatment (19 papers), Pain Management and Opioid Use (14 papers) and Dementia and Cognitive Impairment Research (5 papers). Naama Levy‐Cooperman is often cited by papers focused on Opioid Use Disorder Treatment (19 papers), Pain Management and Opioid Use (14 papers) and Dementia and Cognitive Impairment Research (5 papers). Naama Levy‐Cooperman collaborates with scholars based in United States, Canada and Netherlands. Naama Levy‐Cooperman's co-authors include Sandra E. Black, Edward M. Sellers, Joel Ramirez, Beatrice Setnik, Kerri A. Schoedel, Kenneth W. Sommerville, Nancy J. Lobaugh, Alison B. Fleming, Ernest A. Kopecky and Pierre A. Geoffroy and has published in prestigious journals such as NeuroImage, Stroke and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Naama Levy‐Cooperman

35 papers receiving 696 citations

Peers

Naama Levy‐Cooperman
Beatrice Setnik United States
Anne Roussin France
Azmi Nasser United States
Carmen Walter Germany
Joseph M. Scavone United States
Cathy Stannard United Kingdom
S.E. Abram United States
Enno Freye Germany
João P. De Aquino United States
Ilse Van Hove United States
Beatrice Setnik United States
Naama Levy‐Cooperman
Citations per year, relative to Naama Levy‐Cooperman Naama Levy‐Cooperman (= 1×) peers Beatrice Setnik

Countries citing papers authored by Naama Levy‐Cooperman

Since Specialization
Citations

This map shows the geographic impact of Naama Levy‐Cooperman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naama Levy‐Cooperman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naama Levy‐Cooperman more than expected).

Fields of papers citing papers by Naama Levy‐Cooperman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naama Levy‐Cooperman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naama Levy‐Cooperman. The network helps show where Naama Levy‐Cooperman may publish in the future.

Co-authorship network of co-authors of Naama Levy‐Cooperman

This figure shows the co-authorship network connecting the top 25 collaborators of Naama Levy‐Cooperman. A scholar is included among the top collaborators of Naama Levy‐Cooperman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naama Levy‐Cooperman. Naama Levy‐Cooperman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shram, Megan J., Naama Levy‐Cooperman, Cynthia Huang Bartlett, et al.. (2020). Identification of Optimal Measures of Human Abuse Potential. Journal of Clinical Psychopharmacology. 40(6). 568–578. 1 indexed citations
2.
Mendell, Jeanne, Naama Levy‐Cooperman, Bradley Vince, et al.. (2019). Abuse potential of mirogabalin in recreational polydrug users. Therapeutic Advances in Drug Safety. 10. 584377984–584377984. 13 indexed citations
3.
Schoedel, Kerri A., et al.. (2018). Pharmacokinetic and Pharmacodynamic Correlations From 2 Studies Evaluating Abuse Potential of Hydrocodone Extended‐Release Tablets. Clinical Pharmacology in Drug Development. 8(1). 32–39. 2 indexed citations
4.
Schoedel, Kerri A., et al.. (2018). Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial. Epilepsy & Behavior. 88. 162–171. 130 indexed citations
5.
Setnik, Beatrice, Kerri A. Schoedel, Naama Levy‐Cooperman, et al.. (2017). Evaluating the abuse potential of opioids and abuse-deterrent opioid formulations: A review of clinical study methodology. Journal of Opioid Management. 13(6). 485–523. 6 indexed citations
6.
7.
Levy‐Cooperman, Naama, Gail McIntyre, Mark E. McDonnell, et al.. (2016). Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 359(3). 471–481. 24 indexed citations
8.
Levy‐Cooperman, Naama, Kerri A. Schoedel, Bijan Chakraborty, David Blum, & Hailong Cheng. (2016). Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial. Epilepsy & Behavior. 61. 63–71. 7 indexed citations
9.
Harris, Stephen, Alessandra Cipriano, Salvatore V. Colucci, et al.. (2015). Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users. Pain Medicine. 17(5). 820–831. 21 indexed citations
10.
Setnik, Beatrice, Carl L. Roland, Veeraindar Goli, et al.. (2015). Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States city. Journal of Opioid Management. 11(6). 463–473. 13 indexed citations
11.
Koblan, Kenneth S., Seth C. Hopkins, Kaushik Sarma, et al.. (2015). Assessment of human abuse potential of dasotraline compared to methylphenidate and placebo in recreational stimulant users. Drug and Alcohol Dependence. 159. 26–34. 15 indexed citations
12.
Setnik, Beatrice, Candace Bramson, Almasa Bass, et al.. (2015). Intranasal administration of crushed ALO‐02 (extended‐release oxycodone with sequestered naltrexone): A randomized, controlled abuse‐potential study in nondependent recreational opioid users. The Journal of Clinical Pharmacology. 55(12). 1351–1361. 17 indexed citations
13.
Levy‐Cooperman, Naama, et al.. (2015). Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations with Abuse-Deterrent Properties. Pain Medicine. 16(11). 2142–2151. 36 indexed citations
14.
Reches, Amit, Naama Levy‐Cooperman, Ilan Laufer, et al.. (2014). Brain Network Activation (BNA) Reveals Scopolamine-Induced Impairment of Visual Working Memory. Journal of Molecular Neuroscience. 54(1). 59–70. 12 indexed citations
15.
16.
Schoedel, Kerri A., et al.. (2014). Assessment of human abuse potential of preladenant (a centrally-acting A2A antagonist) compared to phentermine and placebo in recreational stimulant users. Drug and Alcohol Dependence. 146. e91–e91. 1 indexed citations
17.
18.
Ramirez, Joel, Erin Gibson, Abdul Quddus, et al.. (2010). Lesion Explorer: A comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue. NeuroImage. 54(2). 963–973. 87 indexed citations
19.
Nadkarni, Neelesh K., Naama Levy‐Cooperman, & Sandra E. Black. (2010). Functional correlates of instrumental activities of daily living in mild Alzheimer's disease. Neurobiology of Aging. 33(1). 53–60. 27 indexed citations
20.
Levy‐Cooperman, Naama, Nancy J. Lobaugh, Curtis Caldwell, Fuqiang Gao, & Sandra E. Black. (2007). Subcortical Hyperintensities in Alzheimer’s Disease: No Clear Relationship with Executive Function and Frontal Perfusion on SPECT. Dementia and Geriatric Cognitive Disorders. 24(5). 380–388. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatrice Setnik Breakdown of academic impact, for papers by Anne Roussin Breakdown of academic impact, for papers by Azmi Nasser Breakdown of academic impact, for papers by Carmen Walter Breakdown of academic impact, for papers by Joseph M. Scavone Breakdown of academic impact, for papers by Cathy Stannard Breakdown of academic impact, for papers by S.E. Abram Breakdown of academic impact, for papers by Enno Freye Breakdown of academic impact, for papers by João P. De Aquino Breakdown of academic impact, for papers by Ilse Van Hove
Rankless by CCL
2026